JORDAN AHN: Open Payments
NPI 1043903552 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$949 in 49 payments from 16 companies in 2025. Trend: 2023 $64 · 2024 $1,433 · 2025 $949
Food & beverage: $949
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 22 | $307 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $114 |
| Hologic Sales and Service, LLC | 3 | $76 |
| ABBVIE INC. | 4 | $75 |
| ViiV Healthcare Company | 2 | $59 |
| Teva Pharmaceuticals USA, Inc. | 2 | $57 |
| Boston Scientific Corporation | 1 | $47 |
| PFIZER INC. | 2 | $37 |
| Lilly USA, LLC | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
Products named: Yeztugo, XIFAXAN, APTIMA, UBRELVY, APRETUDE, AUSTEDO XR, WaveWriter Alpha Prime 16, MOUNJARO.
Industry payments across CA — which companies pay providers there.
